. Yeast Ire1 performs RIDD both in vivo and in vitro (Related to Figure 1) (A) RIDD in yeast (S. cerevisiae) during ER stress. WT (closed circle), ire1Δ (open circle), or hac1Δ (grey circle) cells were treated with tunicamycin (Tm) for up to 6 hrs and RNA was collected. RNA levels of DAP2 and MFα1 were determined by reverse transcription-followed by quantitative PCR (RT-qPCR). RNA decreased during ER stress only in WT and hac1Δ cells and not in ire1Δ, indicating RIDD where the decrease in RNA is IRE1 dependent, but HAC1 independent. Error bars shown in Figure S1 all represent data from at least three independent repeats.
(F) Activation Profile of yIre1 in vitro. To determine single turnover reaction conditions, HAC1 RNA cleavage reactions were performed with the increasing concentrations of yIre1 ranging from 0.1-5 µM until there was no further increase in HAC1 RNA cleavage activity. k obs (s -1 ) for HAC1 RNA cleavage reaction at different concentration of yIre1 was calculated from profiles of % cleavage of HAC1 RNA throughout time courses performed at different concentrations of yIre1. k obs (s -1 ) stayed at similar values when concentration of yIre1 became higher than 1µM and thus, we chose 3µM Ire1 for the subsequent competition experiments as a single turnover condition.
(G-H) Competition assays described in Figure 1C -1E. Reactions were performed with radiolabeled HAC1 and 3µM yIre1 with increasing amounts of either cold (unlabeled) HAC1 or cold INSULIN RNA (G) or cold XBP1 RNA (H), as indicated.
(I-J) XBP1 RNA cleavage by hIre1 was effectively competed by HAC1 RNA but not INSULIN (RIDD) RNA.
Competition assays were performed with radiolabeled XBP1 RNA and 3µM yIre1 with 15 µM of either cold HAC1 or cold INSULIN RNA. k obs was calculated from reactions shown in I (J).
(K-L) Competition assays described in Figure 1F . Reactions were performed with radiolabeled INSULIN (K) or BLOS1 (L) and 3µM yIre1 with increasing amounts of either cold HAC1 or cold INSULIN RNA, as indicated. (B) Kinetics of XBP1 mRNA splicing and RIDD activity in HEK293 cells when treated with Tg (200nM). Cells were collected at the indicated times and RNA was examined by reverse transcription (RT)-PCR to determine the percentage of spliced XBP1 mRNA by gel-electrophoresis with un-spliced and spliced XBP1 indicated (top panel). XBP1 splicing was calculated by (spliced XBP1/(spliced + unspliced XBP1 mRNA) X100%. The same cDNA was used to perform quantitative PCR (qPCR) using primers complimentary to BLOS1 (orange) and SCARA3 (dark red) mRNA, another RIDD target (Hollien et al., 2009) . RIDD activity was calculated using [(RIDD mRNA in untreated cells -RIDD in treated cells) / RIDD in untreated cells] X100%. Blue line indicates high XBP1 splicing activity at 2 hrs, while the orange & dark red lines indicate the peak of RIDD activity at 8 hrs.
Error bars were generated from at least three independent experiments. It should be noted that XBP1 mRNA splicing activity includes both IRE1 cleavage of the XBP1 intron and the exon ligation steps, while RIDD activity includes degradation of IRE1 cleaved RNA fragments. Thus, the apparent kinetic relationships of XBP1 mRNA splicing and RIDD may over-estimate kinetic differences of IRE1-dependent steps alone in HEK293 cells. This may also contribute differential kinetic relationships of XBP1/HAC1 and RIDD substrate RNA cleavage observed in vivo vs in vitro where both cleavage reactions occurred with similar kinetics (Figures 1A, S1C, S1D).
Alternatively, an additional factor(s) may exist to modulate IRE1 cleavage of either HAC/XBP1 or RIDD substrate RNA in vivo.
(C) Localization of IRE1 RNA substrates. Both XBP1 and RIDD substrate RNA were associated with ER membrane prior to ER stress induction. HEK293 cells were treated with 200nM Tg for up to 8hrs, and cytosol (Cyt) and ER membrane (Mem) fractions were separated using serial detergent extractions as described in (Stephens et al., 2005) . RNAs isolated from these fractions were analyzed by Northern blots probing BLOS1, XBP1, and KAR2/BIP mRNA. Most of both XBP1 and BLOS1 RNA were localized to the ER membrane even prior to UPR induction (compare RNA in the untreated (0) vs Tg treated cells for 1 or 8 hrs). As reported previously, splicing released XBP1 mRNA into the soluble cytoplasmic fraction (Stephens et al., 2005) . In contrast, the majority of GAPDH mRNA was localized to the cytosolic fraction. Consistent with previous reports, some GAPDH was found in the membrane fraction (Stephens et al., 2005) . Standard deviations were calculated from at least three independent experiments.
(D-E) To determine Hill Coefficients, increasing amounts of either yIre1 (D) or hIre1 (E) were used to perform nuclease reactions (Korennykh et al., 2009 ). Un-cleaved and cleaved fragments of RNA were indicated. k obs (s -1 ) were graphed in Figures 3A.
(F) Hill coefficient analysis for HAC1 with the 3' stem loop mutated (HAC1 3' mutant). The 3' stem loop mutation has been shown to block cleavage by IRE1 (Sidrauski and Walter, 1997). Nuclease reactions described in (D) were done using HAC1 3' mutant. Hill Coefficients for HAC1 3' mutant (2.27±0.54) is similar to unmodified WT HAC1 (2.13±0.38), indicating that both are cooperative and that numbers of the cleavage sites do not affect the Hill Coefficients.
(G) H1061N yIre1 is nuclease dead for both HAC1 RNA cleavage and RIDD. Either WT yIre1 or H1061N yIre1 was activated with 2mM ADP for 15 min allowing the cleavage of either HAC1 or BLOS1 RNA.
(H) Oligomerization assays as described in (Korennykh et al., 2009 ) was performed on either WT yIre1, H1061N or R1039A mutants, or interface mutants IF1 c , IF2 c , and IF3 c . At increasing concentrations, WT yIre1, H1061N yIre1 and R1039A yIre1 showed significant increases in OD 500 , while OD 500 for IF1 c , IF2 c and IF3 c yIre1 mutants did not show such increase. WT yIre1 (solid pink), H1061N yIre1 (solid light blue), R1039A yIre1 (solid dark blue), IF1 c mutant E988Q yIre1 (dotted red), IF2 c mutant R1087D yIre1 (dotted maroon), IF3 c mutant R899A yIre1 (dotted green) are shown.
(I) In vitro kinase assay for Ire1 oligomerization mutants. WT and interface mutants IF1 c (E988Q), IF2 c (R1087D), IF3 c (R899A), or a IF2 c /IF3 c double interface mutant were tested for their abilities to undergo autophosphorylation in in vitro. In vitro kinase reactions were performed upon incubation with γ 32 P-ATP, and analyzed by SDD-PAGE, followed by autoradiography. Formation of the back-to-back dimer can be formed with ADP binding to the nucleotide pocket and with quercetin in the Q-site. The back-to-back dimer forms the building block of the IRE1 oligomer ( Figure 3C ) and the interface IF1 c is indicated.
(B) Quercetin (Q) activation of RIDD. Incubation of yIre1 with Q (100µM) induced cleavage of HAC1 RNA at kinetics and the extent similar to that by ADP. Q also induced Ire1 to cleave INSULIN or DAP2 RIDD substrates efficiently in vitro. Precursor mRNA and cleavage products were indicated as previous figures. IRE1 dependent cleavage reactions of both HAC1 and RIDD substrate RNA are faster with Q than ADP. This may be due to the ability of Q to form the back-to-back IRE1 dimer dimers ( Figure S4A ) , which would be a building unit for the fully active oligomerized IRE1. Though no cooporativity between IRE1 is involved ( Figure   3A ), the back-to-back dimer formation may help to stabilize a specific conformation of IRE1 needed for RIDD substrate cleavage. MEFs incubated with Q (450µM) (G) were also activated for XBP1 splicing and RIDD. In this case, however, STF was unable to inhibit BLOS1 RNA cleavage while XBP1 splicing was effectively inhibited. Error bars represent at least three independent experiments. RIDD activity (%) was calculated as described before ( Figure   S3B ). 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES

In Vitro IRE1 Substrates: HAC1, XBP1, and RIDD
HAC1 substrate (508 nt) used in all the in vitro RNase reactions was in vitro transcribed from a plasmid described previously (pCF187) (Sidrauski and Walter, 1997 ATGAGCTCTTGAAATGTCTTCCGCCATC. PCR products were then phenol/chloroform extracted and ethanol precipitated and used as templates for in vitro transcription
In Vitro Transcription of RNA Substrates
In vitro transcription of radiolabeled RNA substrates has been described previously (Chawla et al., 2011; Sidrauski and Walter, 1997) . Briefly, in vitro transcription was performed using T7 RNA polymerase (Promega) at 37 °C, 1mM each of ATP, CTP, GTP, 100µM of UTP, and 50 µCi of α 32 P-UTP (3000Ci/mmol), and 1 µg of template DNA. Transcripts were separated on a 6% UREA-PAGE gel and radiolabeled RNA products were gel extracted by phenol/chloroform followed by ethanol precipitation. Activity of probes was measured by scintillation counter, and diluted to an activity of 20,000 cpm/µl, and based on the efficiency of the scintillation counter, this was equivalent to 10 fmol/µl of radiolabeled RNA.
Unlabeled (cold) RNA was transcribed using MEGAscript T7 Kit (Life Technologies) according to manufacturer's instructions, using 1µg of template DNA. To ensure that the cold RNA was equivalent to the radiolabeled RNA, cold RNA was gel purified side by side with its radiolabeled counterpart. Concentration was then determined upon quantitation by NanoDrop (Thermo).
Protein Purification and Site Directed Mutagenesis
For this study, we used a 6XHis-tagged WT yIre1 containing the entire cytosolic domain (642aa-1115aa) integrated into an expression vector (pET15b). Proteins were expressed in E. coli and purified using a Ni-NTA column (Invitrogen) as described (Sidrauski and Walter, 1997) . Recombinant human IRE1α (hIre1) was expressed and purified using a Baculovirus SF-9 expression system and purified using a Ni-NTA column, as previously described (Niwa et al., 1999) . Point mutations in yIre1 were generated using QuickChange Site Directed Mutagenesis (Stratagene/Agilent) according to manufacturer's instructions using the plasmid containing WT yIre1 (642-1115), and point mutations were confirmed by sequencing.
In vitro Nuclease Assay and Kinetic Analysis
In vitro nuclease assays were performed as described in (Sidrauski and Walter, 1997) . For each time course, an activation curve was generated by plotting time (x) vs. cleaved substrate (y). Using this data, non-linear regression analysis was performed in SigmaPlot (Systat Software, Inc) to generate a curve using the exponential curves function. k obs was generated using the initial slope of the generated curve obtained in SigmaPlot.
Determination of Hill Coefficients
Hill Coefficients were determined as previously described in (Korennykh et al., 2009) . Briefly, standard nuclease assays were set up with nuclease buffer, 2mM ADP, and varying concentrations of either yIre1 or hIre1, as described. Reactions were performed in 20µl, and started when 0.5nM radiolabeled RNA (either HAC1, INSULIN, HAC1 3' mut for yIre1 or XBP1, INSULIN for hIre1) was added. Reactions were stopped with stop buffer and analyzed on 6% UREA gel, and molar values for uncleaved and cleaved products were calculated. For each concentration of Ire1, k obs was calculated as described above and values were plotted ([Ire1] vs k obs ) and fitted using GraphPad Prism 5 (La Jolla, CA). The Hill coefficient was calculated by Prism using a four parameter logistic equation under the sigmoidal dose response curve with variable slope function. We interpret a non-cooperative Hill coefficient of 1 as IRE1 acting within a dimer since monomeric IRE1 is inactive (Lee et al., 2008) . Experiments were done at least three times with standard deviations shown.
Structural Analysis of IRE1
Structural analysis was done using Chimera (http://www.cgl.ucsf.edu/chimera) (Pettersen et al., 2004) and structure prediction was done using Phyre2 (www.sbg.bio.ic.ac.uk/phyre2/) (Kelley and Sternberg, 2009 ).
Structures used were: 3FBV (Korennykh et al., 2009 ) for yIre1 oligomers (Figure 3C) , 3P23 (Ali et al., 2011) for hIre1 face to face dimer ( Figure S4A) , 2RIO (Lee et al., 2008) for ADP activated yIre back to back dimer ( Figure   S4A ), and 3LJO for quercetin activated yIre1 back to back dimer ( Figure S4A) . 
Cell Culture and IRE1 Foci Microscopy
Yeast Culture and Northern Blots
Yeast strains used in this study were described in (Chawla et al., 2011); WT (MNY1000), ire1Δ (MNY1655), hac1Δ (MNY1662). Yeast strains were grown in YPD medium (1% yeast extract, 2% bactopeptone, and 2% glucose) at 30 °C to an OD 600 of ~0.5 before Tunicamycin (Tm) to a final concentration of 1µg/ml was added and incubated for indicated length of time. At each time point, cells were collected and RNA was isolated for Northern Blot analyses as described previously (Chawla et al., 2011) . Briefly, RNA was extracted using the hot phenol method, and RNA was separated on 1.5% agarose gels containing 6.7% formaldehyde and transferred to a Duralon-UV membrane (Agilent Technologies). Splicing of HAC1 mRNA was examined by hybridization of the membrane with radiolabeled HAC1 probe at 65 °C overnight, and exposed via phosphoimager screen (GE Healthcare). Quantitation was performed using a Typhoon Imager system (GE Healthcare).
Kinase Assay
In vitro Kinase assays were performed as described (Chawla et al., 2011) . WT yIre1 or mutant yIre1 proteins were incubated in kinase buffer (10mM Hepes pH 7.5, 5mM Mg(OAc) 2 , 25mM KOAc, 1mM DTT) with 200 µM of unlabeled ATP and 167 µCi of 32 Pγ-ATP (7000Ci/mmol) in a volume of 20µl. Reactions were incubated at 30 °C for 30 min, and hot SDS Loading Buffer and incubation at 95 °C was used to stop the reaction. Samples were immediately run on a 7% SDS-PAGE gel. Phosphorylation was determined by autoradiography and scanned on a Typhoon 9400 (GE Healthcare).
Fractionation of ER
Cells were treated for up to 8 hrs as indicated, washed twice with PBS, and re-suspended in Fractionation Buffer:
10mMHEPES [pH 7.4], 1mM EDTA, 0.25Msucrose, protease inhibitors (Leupeptin, Pepstatin, Aprotinin). Cells were then homogenized by passage through a 27 gage needle and centrifuged at 500Xg for 3min at 4 °C. 150µl of supernatant was then mixed with 2.5M sucrose in Fractionation Buffer, and a flotation gradient was assembled with 1.8M, 1.3M, 0.8M sucrose fractions, with the 1.3M fraction containing the rough microsomes. The gradient was centrifuged at 100,000Xg for 12 hrs, and the 1.3M and 2.5M solutions, corresponding to the ER and cytosolic portions, respectively, were collected. RNA was then extracted using Trizol (Invitrogen) and 10µg of RNA of each fraction was used for Northern Blots as described above.
Oligomerization Assay
Oligomerization assay was done as previously reported (Korennykh et al., 2011) . Briefly, reactions were set up using nuclease reaction buffer (40mM Hepes, 7.0, 10mM Mg(OAc) 2 , 50mM KOAc, 5mM DTT), the indicated amount of WT or mutant yIre1, and 2mM ADP. All reactions were performed in 20µl and incubated for 15 min at 30 °C to allow for oligomerization. The optical density of the sample was measured at 500 nm using a UVvisible spectrophotometer (NanoDrop 2000, Thermo Scientific). Readings were blanked using a reaction without yIre1.
Cell Culture and Determination of XBP1 Splicing and RIDD in vivo
All mammalian cells were cultured in DMEM media (Cellgro) with 10% FBS and 100 U/ml penicillin, and 100ug/ml streptomycin (Mediatech). Cells were grown in 5% CO 2 at 37°C and treated with 200nM Thapsigargin (Calbiochem), 450µM Quercetin (Sigma), or STF-083010 (60µM) (Papandreou et al., 2011) as indicated.
Determination of spliced XBP1 was performed as described (Lin et al., 2007) . Briefly, total RNA was prepared from cells using Trizol (Invitrogen), and 1µg of total RNA was reverse transcribed using Maxima Reverse Transcriptase (Fermentas) to obtain cDNA. cDNA was then PCR amplified using the primers for XBP1:
5'-TTACGGGAGAAAACTCACGGC-3' and 5'-GGGTCCAACTTGTCCAGAATGC-3', resulting in a 289 bp fragment corresponding to unspliced XBP1, and a 263 bp spliced XBP1 fragment. Fragments were resolved on a 2.5% agarose gel, and quantified using a Typhoon 9400 fluorescent scanner (GE Healthcare). XBP1 splicing % was calculated by: [(spliced XBP1/(spliced XBP1+ unspliced XBP1)]X100%.
Determination of RIDD was performed as described (Hollien et al., 2009) . Briefly, the same cDNA from
